ADVFN US – Market Content Editor
-
SciSparc Shares Surge After Company Moves to Acquire GERD Treatment Technology
SciSparc Ltd. (NASDAQ:SPRC) jumped 26.8% in premarket trading on Wednesday after the clinical-stage pharmaceutical firm announced it has entered into a binding term sheet to acquire patents and intellectual property tied to advanced endoscopic systems—including the MUSE™ device—from Xylo Technologies Ltd. The MUSE™ system is a disposable, single-use endoscopic tool used for transoral fundoplication, a…
-
Obook Shares Jump After Company Launches $10 Million Buyback Program
Obook Holdings Ltd (NASDAQ:OWLS) surged 4.5% in premarket trading on Wednesday following the company’s announcement of a new $10 million share repurchase initiative. The blockchain technology firm said the nine-month program authorizes the repurchase of its Class A common stock using a range of methods, including open-market transactions, privately negotiated deals, and block trades. According…
-
Chijet Shares Jump as Company’s Digital Asset Portfolio Tops $400 Million
Chijet Motor Company, Inc. (NASDAQ:CJET) saw its shares climb 8.3% in premarket trading on Wednesday after the company disclosed that the value of its digital asset treasury has now exceeded $400 million. The automaker said it has accumulated 100 million tokens under the digital asset strategy it unveiled earlier this month—part of a broader effort…
-
SuperX AI Shares Climb After Company Unveils $20 Million Buyback Program
SuperX AI Technology Limited (NASDAQ:SUPX) saw its shares rise 3.4% in premarket trading on Wednesday after the company rolled out a new share repurchase initiative worth up to $20 million over the next 12 months. The AI infrastructure firm said its board has approved the plan, giving SuperX the flexibility to buy back shares either…
-
U.S. Jobless Claims Drop, Surprising Forecasters
New data shows a decline in initial jobless claims in the United States, signaling a firmer labor market than analysts had anticipated. First-time claims for unemployment benefits fell to 216,000, down from 222,000 the previous week. This result came in well below market expectations, which had projected a reading of 226,000. The sharper-than-expected drop is…
-
U.S. Durable Goods Orders Match Expectations but Show Slower Momentum
New data shows that U.S. durable goods orders—a closely watched indicator of manufacturing activity—rose 0.5% in the latest month, exactly in line with economists’ forecasts. The report, which tracks new orders for long-lasting manufactured items such as vehicles, industrial machines, and household appliances, is often used to assess the sector’s forward momentum. A result that…
-
Dow Jones, S&P, Nasdaq, Wall Street Futures, U.S. Stocks Set to Build on Recent Gains
U.S. equity futures pointed to a slightly higher open on Wednesday, suggesting that major indexes may extend the rebound that has taken shape over the past several sessions. The recent momentum has helped the Dow, S&P 500, and Nasdaq recover sharply from the steep decline earlier in the month, with traders appearing less concerned about…
-
Nvidia Slips in Premarket as Questions Mount Over Its AI Chip Lead
Nvidia (NASDAQ:NVDA) edged lower in U.S. premarket trading on Wednesday, hinting at a continuation of the previous session’s weakness as investors reassessed the chipmaker’s long-standing dominance in the artificial intelligence hardware market. The stock dropped 2.6% on Tuesday and is now down about 12% so far this month, marking a notable reversal for a company…
-
CollPlant Shares Slip After Q3 Revenue Misses Expectations
CollPlant Biotechnologies (NASDAQ:CLGN) traded lower in premarket action on Wednesday after reporting third-quarter revenue of $77,000—well below the analyst consensus of $2.76 million. The stock dipped 0.89% following the announcement. The regenerative medicine company posted an adjusted loss of $0.25 per share, missing expectations for earnings of $0.16 per share. While revenue improved from just…
-
Valneva Shares Rise on Strong Booster Results for Lyme Disease Vaccine Candidate
Valneva SE (NASDAQ:VALN) saw its stock move higher on Wednesday after the company released final Phase II results for its Lyme disease vaccine candidate, VLA15, showing robust immune responses following a third annual booster shot. According to the data, participants across all age groups—children, adolescents, and adults—mounted strong anamnestic antibody responses to all six serotypes…